Radiation Therapy for the Management of Renal Medullary Carcinoma: A Multi-Case Study
- 5 March 2024
- journal article
- research article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 22 (3) , 102065
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Gateway for Cancer Research
This publication has 15 references indexed in Scilit:
- Renal Cell Carcinoma of Variant HistologyHematology/Oncology Clinics of North America, 2023
- Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature reviewTherapeutic Advances in Urology, 2023
- Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinomaClinical Genitourinary Cancer, 2021
- Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint InhibitorsJAMA Network Open, 2021
- Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary CarcinomaCancer Cell, 2020
- Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary CarcinomaClinical Genitourinary Cancer, 2019
- A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary CarcinomaClinical Cancer Research, 2018
- Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinomaJournal for ImmunoTherapy of Cancer, 2017
- Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative studyBJU International, 2016
- A Phase 2 Trial of Sunitinib in Patients with Advanced Non–clear Cell Renal Cell CarcinomaEuropean Urology, 2012